NeurosciencesPharmacology & PharmacySCI(E)PubMed0CORRECTIONhashimoto@faculty.chiba-u.jp3243-2431
[[abstract]]Ketamine, an N-methyl-d-aspartate receptor (NMDAR) blocker, is gaining ground as a treat...
Previous research has shown that depression inhibits neruogenesis in the dentate of the hippocampus ...
Depression is characterized by a loss of synaptic connections in regions of the brain involved in em...
Objective: Pediatric depression is associated with significant functional impairment at school and a...
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is one of the most attractive antidepre...
The National Institutes of Mental Health has portrayed major depressive disorder (MDD) to affect app...
Approximately 10% of children and adolescents are diagnosed with major depressive disorder (MDD). Cu...
Major depression is a stress-linked disease with significant morbidity and the anesthetic drug ketam...
Major Depressive Disorder (MDD) is one of the most severe and potentially debilitating forms of mood...
Early-life exposure to ketamine mediates an anxiolytic effect in adulthood. Epidemiological reports ...
Ketamine has been shown to produce rapid and robust antidepressant effects in depressed individuals,...
Depression is a common mental disorder that is associated with memory dysfunction. Ketamine has rece...
Major depression is a stress-linked disease with significant morbidity and the anesthetic drug ketam...
PubMedID: 31522257Ketamine (KET), an anesthetic, analgesic, and a sedative N-methyl-d-aspartate (NMD...
Ketamine (KET), a NMDA receptor antagonist, has been studied for its rapid and efficacious antidepre...
[[abstract]]Ketamine, an N-methyl-d-aspartate receptor (NMDAR) blocker, is gaining ground as a treat...
Previous research has shown that depression inhibits neruogenesis in the dentate of the hippocampus ...
Depression is characterized by a loss of synaptic connections in regions of the brain involved in em...
Objective: Pediatric depression is associated with significant functional impairment at school and a...
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is one of the most attractive antidepre...
The National Institutes of Mental Health has portrayed major depressive disorder (MDD) to affect app...
Approximately 10% of children and adolescents are diagnosed with major depressive disorder (MDD). Cu...
Major depression is a stress-linked disease with significant morbidity and the anesthetic drug ketam...
Major Depressive Disorder (MDD) is one of the most severe and potentially debilitating forms of mood...
Early-life exposure to ketamine mediates an anxiolytic effect in adulthood. Epidemiological reports ...
Ketamine has been shown to produce rapid and robust antidepressant effects in depressed individuals,...
Depression is a common mental disorder that is associated with memory dysfunction. Ketamine has rece...
Major depression is a stress-linked disease with significant morbidity and the anesthetic drug ketam...
PubMedID: 31522257Ketamine (KET), an anesthetic, analgesic, and a sedative N-methyl-d-aspartate (NMD...
Ketamine (KET), a NMDA receptor antagonist, has been studied for its rapid and efficacious antidepre...
[[abstract]]Ketamine, an N-methyl-d-aspartate receptor (NMDAR) blocker, is gaining ground as a treat...
Previous research has shown that depression inhibits neruogenesis in the dentate of the hippocampus ...
Depression is characterized by a loss of synaptic connections in regions of the brain involved in em...
DOI
Add to ORKG